Article Text

Download PDFPDF
Extended report
Measure of function in rheumatoid arthritis: individualised or classical scales?
  1. R Seror1,
  2. F Tubach1,
  3. G Baron1,
  4. F Guillemin2,
  5. P Ravaud1
  1. 1
    AP-HP, Hôpital Bichat, Département d’Epidémiologie, Biostatistique et Recherche Clinique, Paris, France; Université Paris, Paris, France
  2. 2
    INSERM, Centre d’Epidémiologie Clinique Nancy; CHU de Nancy, Service d’épidémiologie et évaluation cliniques, Nancy; Nancy-Université, Vandoeuvre-les-Nancy, France
  1. Correspondence to Dr R Seror, Département d’Epidémiologie, Biostatistique et Recherche Clinique, INSERM U738, Hôpital Bichat, 46 rue Henri Huchard, 75018 Paris, France;{at}


Background: The Health Assessment Questionnaire Disability Index (HAQ-DI) is the most widely used measure of function in rheumatoid arthritis (RA).

Objective: To evaluate individualised forms of the HAQ-DI and thus enhance the incorporation of patients’ views in outcome assessment.

Patients and methods: HAQ-DI data were prospectively obtained from 370 outpatients with RA treated with leflunomide over a 6-month period. At baseline and final visits, patients had to rate the importance they attached to each activity addressed by the 20 HAQ-DI items, and to select the five activities they considered the most important. Different individualised scales were evaluated: scales preserving all domains, in which the score for each item is multiplied by or added to its importance; and scales involving, for each patient, only the five most important items. The psychometric properties of these scales were compared with those of the HAQ-DI.

Results: For each HAQ-DI item, severity and importance scores were weakly correlated. Scores for all individualised scales were highly correlated with the HAQ-DI score (rs>0.75). All scales had a good internal consistency (Cronbach’s α 0.87–0.88). Compared with the HAQ-DI, individualised scales did not have better sensitivity to change (standardised response mean 0.64–0.69 vs 0.74).

Conclusion: Individualised scales have similar properties to the HAQ-DI. However, individualised questionnaires measuring importance gave complementary information to the measure of disability. Individualisation is probably not needed for group assessment in all randomised controlled trials but, the use of individualised questionnaires may be clinically relevant for individual patients with RA.

Statistics from


  • ▸ An additional figure is published online only at

  • Funding This study was supported by a by an unrestricted grant from Sanofi-Aventis Laboratories, France.

  • Competing interests None.

  • Ethics approval Ethics approval from local ethics committees.

  • Patient consent Patient consent received.

  • Provenance and Peer review Not commissioned; externally peer reviewed.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.